Dr. Scott Sherman M.D. to Head Up
CannaVision (OTC: $SVSN) Medical Cannabis and Pain Management Clinic in
Sunrise, Florida
LAS VEGAS, NV - December 14, 2017
(Investorideas.com Newswire) StereoVision Entertainment, Inc. (OTC PINK: SVSN),
a publicly traded Nevada Corporation announced today that their majority-owned
medical cannabis/industrial hemp subsidiary CannaVision has signed Dr. Scott
Sherman M.D. to head up a CannaVision Medical Cannabis and Pain Management
Clinic in Sunrise, Florida.
Read this news in full at http://www.investorideas.com/news/2017/marijuana/12141OTCSVSN.asp
"We're happy to welcome Dr. Sherman to
CannaVision's medical staff," said CannaVision's Chairman and Chief
Medical Officer Dr. Jay Ellenby M.D. "Our primary focus is treating vets
and cancer patients and I look forward to working with Dr. Sherman. The Miami
medical cannabis clinic market has quickly become overcrowded so we're moving
our Coral Gables clinic operations to Sunrise. With Sunrise centered amidst a
number of VA medical facilities and cancer treatment centers this area best
serves our purpose."
StereoVision Entertainment Inc. http://stereovision.com Headquartered
in Las Vegas, Nevada StereoVision is a publicly traded Nevada corporation
(OTC:SVSN) focused on creating, acquiring, and producing multimedia content
with its media subsidiaries, the wholly owned 9 time Emmy Award-winning
production company REZN8, http://rezn8.com,
the majority-owned family entertainment company, Inspirational Vision Media,
Inc. http://ivmi.biz,
and the majority-owned medical cannabis clinic and industrial hemp Florida C
corporation MediCannaVision Inc., dba CannaVision. http://cannavisionclinics.com
Safe Harbor Statement: Except for historical
information certain statements in this news release may contain forward-looking
information within the meaning of Rule 175 under the Securities Act of 1933 and
Rule 3b-6 under the Securities Exchange Act of 1934, and those statements are
subject to the safe harbor created by those rules. All statements, other than
statements of fact, included in this release, including, without limitation,
statements regarding potential plans and objectives of the Company, are
forward-looking statements that involve risks and uncertainties. There can be
no assurance that such statements will prove to be accurate and actual results
and future events could differ materially from those anticipated in such
statements. The Company cautions that these forward-looking statements are
qualified by other factors. The Company undertakes no obligation to publicly
update any statements in this release.
Contact:
Steve Previch
305-972-1030
Steven@cannavisionclinics.com
305-972-1030
Steven@cannavisionclinics.com
Disclaimer: This
directory is not a recommendation to buy or sell securities or products or
services Investorideas.com charges a fee for placement. The directory is not an
endorsement or recommendation but meant to be an investor resource/ due
diligence tool.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced
news, articles and equity research as well as creates original content,
including video, interviews and articles. Original content created by
investorideas is protected by copyright laws other than syndication rights. Our
site does not make recommendations for purchases or sale of stocks, services or
products. Nothing on our sites should be construed as an offer or solicitation
to buy or sell products or securities. All investment involves risk and
possible loss of investment. This site is currently compensated for news
publication and distribution, social media and marketing, content creation and
more. Contact each company directly regarding content and press release
questions. Disclosure is posted for each compensated news release, content
published /created if required but otherwise the news was not compensated for
and was published for the sole interest of our readers and followers. More
disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Disclosure: Companies Featured on the 420 Cannabis
Investor Ideas have paid a one-time fee of Up to $1000 to be featured on the
directory. http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info regarding BC Residents and global
Investors: Effective September 15 2008 - all BC investors should review all OTC
and Pink sheet listed companies for adherence in new disclosure filings and
filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
No comments:
Post a Comment